Valuation: PeptiDream Inc.

Market Cap 132B 835M 715M 666M 614M 1.15B 79.92B 1.17B 7.81B 3.08B 40.15B 3.14B 3.07B P/E 2026 *
10.4x
P/E 2027 * 10.6x
Enterprise Value 102B 647M 554M 516M 476M 893M 61.96B 909M 6.06B 2.39B 31.13B 2.43B 2.38B EV / Sales 2026 *
2.3x
EV / Sales 2027 * 2.02x
Free-Float
72.4%
Yield 2026 *
-
Yield 2027 * 0.39%
1 day+0.15%
1 week+3.51%
Current month+8.42%
1 month+5.34%
3 months-8.22%
6 months-26.01%
Current year-38.00%
1 week 972.5
Extreme 972.5
1,073
1 month 906.4
Extreme 906.4
1,073
Current year 906.4
Extreme 906.4
1,788
1 year 906.4
Extreme 906.4
1,818.5
3 years 906.4
Extreme 906.4
3,060
5 years 906.4
Extreme 906.4
4,140
10 years 906.4
Extreme 906.4
6,540
Manager TitleAgeSince
Chief Executive Officer 51 31/12/2021
Chief Operating Officer - 01/07/2026
Chief Tech/Sci/R&D Officer - 31/03/2024
Director TitleAgeSince
Director/Board Member 51 31/07/2008
Director/Board Member 51 31/08/2017
Director/Board Member 55 28/02/2021
Change 5-day change 1-year change 3-year change Capi.($)
+0.15%+3.51%-32.90%-40.65% 826M
-1.90%+2.37%+69.11%+110.88% 73.45B
+0.87%+17.17%+53.05%+95.59% 62.99B
+1.71%-1.44%+2.66%+501.29% 28.05B
-1.40%+4.18%+54.52%+19.60% 25.42B
+21.96%+21.90%+0.51%+2.50% 23.3B
+2.28%+7.98%+42.75%-12.34% 19.45B
0.00%-4.11%+243.99%+423.83% 18.16B
-3.50%-0.95%+17.17%+534.55% 16.53B
+2.39%+5.96%+44.04%+157.77% 13.16B
Average +0.09%+2.80%+49.49%+179.30% 28.14B
Weighted average by Cap. -0.16%+4.38%+56.83%+167.49%

Financials

2026 *2027 *
Net sales 44.47B 281M 241M 224M 207M 388M 26.91B 395M 2.63B 1.04B 13.52B 1.06B 1.03B 45.74B 289M 248M 231M 213M 399M 27.68B 406M 2.71B 1.07B 13.91B 1.09B 1.06B
Net income 12.77B 80.71M 69.15M 64.36M 59.36M 111M 7.73B 113M 755M 298M 3.88B 303M 297M 12.55B 79.33M 67.97M 63.26M 58.34M 110M 7.6B 111M 743M 293M 3.82B 298M 292M
Net Debt -29.66B -188M -161M -150M -138M -259M -17.96B -263M -1.76B -691M -9.02B -705M -689M -39.87B -252M -216M -201M -185M -348M -24.13B -354M -2.36B -929M -12.12B -947M -926M
Logo PeptiDream Inc.
PeptiDream Inc. is a Japan-based bio-venture company started by the University of Tokyo and principally engaged in the discovery and development of non-standard peptide therapeutics. The Company operates the Peptide Discovery Platform System (PDPS), a drug development platform system and conducts research and development (R&D) on new drug candidates based on the joint R&D with pharmaceutical companies in Japan and overseas. The Company is involved in the business centered on drug development based on special peptides. The Company's businesses include drug discovery joint R&D, PDPS technology loan (PDPS technology license) and expansion of its own pipeline through strategic alliance (strategic alliance or in-house drug discovery).
Employees
645
Date Price Change Volume
19/08/26 JP¥1,027.00 +0.15% 957,400
18/08/26 JP¥1,025.50 +2.29% 1,416,800
17/08/26 JP¥1,002.50 -2.81% 1,431,900
14/08/26 JP¥1,031.50 -1.39% 1,484,800
13/08/26 JP¥1,046.00 +3.87% 2,206,800
Trader
Investor
Global
Quality
ESG MSCI
BB
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
6
Last Close Price
1,027.00JPY
Average target price
2,725.00JPY
Spread / Average Target
+165.34%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. 4587 Stock